Biocompatibility and Dental Applications of 3D Printing

3D printing has profoundly transformed the dental industry over the past decade. What began as a technology primarily used to manufacture study models has evolved into a tool capable of producing occlusal splints, aligners, surgical guides, temporary crowns, removable dentures, custom impression trays, and even frameworks for complex rehabilitations. This technological revolution has made it possible to reduce manufacturing times, improve precision, and deliver increasingly personalized solutions for each patient.

However, alongside the advantages of additive manufacturing, new regulatory responsibilities have emerged. In Europe, any medical device manufactured using 3D printing for clinical use must comply with the requirements established by Regulation (EU) 2017/745 on medical devices, commonly known as the MDR (Medical Device Regulation). Although many professionals associate this regulation exclusively with large medical device manufacturers, the reality is that it directly affects dental laboratories, milling centers, dental clinics that manufacture certain devices in-house, and companies developing digital solutions for dentistry.

Understanding how the MDR applies to dental 3D printing is essential not only for ensuring legal compliance but also for safeguarding patient safety and treatment quality.

Dental 3D Printing as Medical Device Manufacturing

One of the most common misconceptions is that 3D printing is simply a production technique and that regulatory responsibility lies solely with the manufacturer of the resin or printing equipment. However, from the MDR perspective, the party that manufactures a device intended for use on a patient is responsible for demonstrating that the device is safe and suitable for its intended purpose.

This means that when a dental laboratory manufactures an occlusal splint using 3D printing, or produces a surgical guide for implant placement, it is participating in the manufacture of a regulated medical device. The responsibility extends far beyond printing a part; it encompasses the entire process, from digital design to post-processing, cleaning, final photopolymerization, and delivery of the device to the healthcare professional.

Digital manufacturing has also introduced a new level of complexity: the final quality of the product no longer depends solely on the material used but also on multiple process variables. Print orientation, exposure parameters, printer calibration, part washing, and the curing process can all significantly influence the mechanical and biological properties of the final device.

For this reason, the MDR requires the manufacturing process to be controlled and documented.

The Role of Custom-Made Medical Devices in Dentistry

Most 3D-printed devices used in dentistry are classified as custom-made medical devices. This includes occlusal splints, surgical guides, customized orthodontic appliances, temporary prostheses, and other products specifically designed for an individual patient based on a prescription issued by a dentist.

Custom-made devices are subject to a specific regulatory framework under the MDR. Unlike mass-produced devices, they do not require individual CE marking on each device manufactured for a patient. However, this does not mean they are exempt from the regulation.

The manufacturer must be able to demonstrate that the product complies with the general safety and performance requirements established by the regulation. In addition, documentation must be maintained to identify the patient, the prescribing professional, the materials used, and the manufacturing procedures applied.

In practice, this means that a dental laboratory manufacturing 3D-printed occlusal splints must have documented procedures, material traceability, and production records that make it possible to fully reconstruct the manufacturing history of every device.

The Importance of Certified Materials for Dental 3D Printing

One of the most critical aspects of dental additive manufacturing is material selection.

The photopolymer resins used for clinical applications are not simply printing resins. They must have been specifically developed for medical use and be supported by the technical documentation required to demonstrate their safety.

In most cases, material manufacturers provide information on testing conducted in accordance with the ISO 10993 series of biocompatibility standards and, in the dental field, the ISO 7405 standard for the biological evaluation of dental materials.

It is important to understand that the dental laboratory is generally not required to repeat these tests for every manufactured device. However, it must retain the documentation provided by the material manufacturer and verify that the intended use matches the clinical application for which the resin has been validated.

For example, a resin designed for manufacturing dental models cannot automatically be used to produce occlusal splints. Although both applications use the same printing technology, their contact with the patient is entirely different, and therefore so are their safety requirements.

Biocompatibility: Much More Than a Certificate

Biocompatibility is probably one of the most important concepts in the manufacture of 3D-printed dental devices.

When an occlusal splint remains in contact with the oral mucosa for several hours each day, or when a surgical guide comes into contact with tissues during a procedure, the material must be capable of interacting with the body without causing adverse effects.

The term "biocompatibility certificate" is frequently used, but from a regulatory perspective the concept is more complex. European legislation does not require the existence of a single biocompatibility certificate. Instead, it requires sufficient evidence demonstrating that the product is safe for its intended use.

This evidence is typically based on testing conducted in accordance with the ISO 10993 series, which evaluates aspects such as cytotoxicity, irritation, and sensitization.

Cytotoxicity assesses whether the material can damage living cells. Irritation studies evaluate its potential to cause localized inflammation. Sensitization testing determines the risk of triggering allergic reactions after repeated exposure.

Devices involving longer-term or more invasive contact may require additional studies, including toxicological assessments and detailed chemical analyses of substances released by the material.

The Printing Process Is Just as Important as the Resin

One of the major mindset shifts introduced by the MDR is the recognition that the safety of a medical device depends as much on its manufacturing process as on its materials.

Insufficient washing of a printed part may leave uncured monomer residues. Inadequate curing can alter the mechanical and biological properties of the material. A poorly calibrated printer may produce inaccurate geometries that compromise the clinical fit of the device.

For this reason, material manufacturers' validation studies typically specify precise printing parameters, compatible equipment, and post-processing protocols.

When a laboratory significantly modifies these parameters, it may be moving away from the conditions under which the material's safety was originally demonstrated.

Traceability and Documentation in the Digital Environment

Digital dentistry generates an enormous amount of information that can be used to improve traceability.

STL files, CAD design records, resin batch numbers, printing parameters, washing cycles, and curing programs can all be stored digitally and linked to each manufactured device.

From a regulatory standpoint, this information is extremely valuable. In the event of an incident, it makes it possible to quickly identify which materials were used, which printer produced the device, and which manufacturing protocols were applied.

Traceability is no longer merely a legal requirement; it has become an essential tool for ensuring the quality and reproducibility of treatments.

Towards Safer Digital Dentistry

3D printing represents one of the most promising technologies for the future of dentistry. Its ability to manufacture customized devices quickly and accurately is transforming the way treatments are planned and carried out.

However, this technological revolution must be accompanied by a strong culture of quality and regulatory compliance. The MDR should not be viewed as a barrier to innovation but rather as a framework designed to ensure that the benefits of digital manufacturing reach patients with the highest possible standards of safety.

For dental laboratories, clinics, and manufacturers of digital solutions, understanding the principles of the MDR, risk management, traceability, and biocompatibility is no longer an issue reserved for regulatory departments. It has become an essential competency for any professional working with additive manufacturing technologies in healthcare.

As 3D printing continues to evolve and new materials, equipment, and clinical applications emerge, knowledge of European regulations will become just as important as mastering the design and printing processes themselves. Only in this way will it be possible to unlock the full potential of digital dentistry while maintaining the levels of safety and quality required by modern clinical practice.